Overview
Achieving sustained blood levels of carbidopa/levodopa has been a challenge in the treatment of PD and although levodopa remains the most commonly used drug, motor fluctuations remain a major disability especially in advanced Parkinson's disease. The aim of this study is to determine the efficacy of a novel oral carbidopa-levodopa formulation in achieving a sustained blood level of levodopa and carbidopa in normal volunteers.
Eligibility
Inclusion Criteria:
- Normal healthy
- Are 18-65 years of age
- Are not currently taking medications regularly
- Able to fast 6 hours (water allowed)
Exclusion Criteria:
- Pregnancy
- Inability to fast